<DOC>
	<DOCNO>NCT01236872</DOCNO>
	<brief_summary>Inorganic nitrate convert nitrite thence nitric oxide human . Nitric oxide normally produce inner line blood vessel help keep blood vessel open therefore blood pressure lower . In subject high blood pressure , inner line blood vessel function adequately . The investigator wish investigate whether elevate systemic level inorganic nitrate ( provision dietary nitrate-rich vegetable ) elevate level nitrate/nitrite hypertensive subject , whether beneficial effect blood pressure .</brief_summary>
	<brief_title>The Acute Effect Beetroot Juice Normal Hypertensive Subjects</brief_title>
	<detailed_description />
	<criteria>1 . Adult male female 18 85 year age , inclusive . 2 . To eligible , female subject require state pregnant , become pregnant course study . 3 . Body mass index ( BMI ) 18 40 kg/m2 4 . A signed date write informed consent prior admission study 5 . The subject able understand comply protocol requirement , instruction protocolstated restriction . 6 . Grade 1 hypertensive SBP 140159 DBP 9099 antihypertensive , target organ damage ( TOD ) , low cardiovascular disease ( CVD ) risk 1 . History symptomatic coronary artery disease , stroke , know atherosclerotic disease . 2 . History chronic viral hepatitis ( include presence hepatitis B surface antigen hepatitis C antibody ) , chronic hepatic disorder . 3 . History increase liver function test ( ALT , AST ) due acute chronic liver condition , 3x upper limit normal bilirubin 1.5x upper limit normal screening . 4 . Renal impairment creatinine clearance ( eGFR ) &lt; 50 ml/min screening . 5 . Current poorly control diabetes mellitus , define HbA1c &gt; 10 % Screen . 6 . Subjects LDLc , &gt; 7.5 mmol/l . Fasting TG level &gt; 6mmol/l . 7 . History heart failure define NYHA class II IV know severe LV dysfunction ( EF &lt; 30 % ) regardless symptomatic status 8 . History malignancy within past 5 year , nonmelanoma skin cancer . 9 . Current lifethreatening condition vascular disease ( e.g. , severe chronic airway disease , HIV positive , lifethreatening arrhythmia ) may prevent subject complete study . 10 . Alcohol drug abuse within past 6 month . 11 . Use investigational device investigational drug within 30 day 5 halflives ( whichever longer ) precede first dose study medication . 12 . Subjects commence likely commence treatment nonsteroidal antiinflammatory drug ( NSAIDs ) ( aspirin ) , screen study completion . 13 . Any nonstable dosing ongoing medication regimen throughout study trial . 14 . The subject three month prior history regular alcohol consumption exceed average weekly intake &gt; 28 unit ( average daily intake great 3 unit ) male , average weekly intake &gt; 21 unit ( average daily intake great 2 unit ) female . 1 unit equivalent halfpint ( 284mL ) beer/lager ; 25mL measure spirit 125mL wine ; positive alcohol breath test screen visit 15 . A positive urine test drug abuse ( relate know medication subject take , ie , codeine pain management ) alcohol screen prior study medication administration . 16 . Any subject Investigator deems unsuitable study ( e.g. , due either medical reason , laboratory abnormality , expect study medication noncompliance , subject 's unwillingness comply studyrelated study procedure ) . 17 . Subjects rheumatoid arthritis , connective tissue disorder condition know associate chronic inflammation ( e.g . Inflammatory Bowel Disease ) . 18 . Subjects acute infection , significant trauma ( burn , fracture ) . 19 . Subjects donate 500 mL blood within 56 day prior initiation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Nitrate</keyword>
	<keyword>Nitrite</keyword>
	<keyword>Vegetable</keyword>
	<keyword>Aortic stiffness</keyword>
</DOC>